Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry|January 13, 2000
Three-dimensional quantitative structure-activity studies of octopaminergic agonists responsible for the inhibition of sex-pheromone production in Helicoverpa [correction of Hercoverpa] armigeraA Hirashima, A Rafaeli, C Gileadi, et al.Microbiology and Immunology|January 1, 1983
Distribution of RNA coliphages in Senegal, Ghana, and MadagascarK Furuse, T Sakurai, Y Inokuchi, et al.Gut|February 16, 2005
Amelioration of 2,4,6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout miceY Inokuchi, T Morohashi, I Kawana, et al.Dental Materials Journal|January 20, 1999
Evaluation of cytotoxicity of calcium phosphate cement consisting of alpha-tricalcium phosphate and dicalcium phosphate dihydrateS Higashi, T Ohsumi, K Ozumi, et al.Molecular Microbiology|March 1, 1989
Molecular characterization of a cell wall-associated proteinase gene from Streptococcus lactis NCDO763M Kiwaki, H Ikemura, M Shimizu-Kadota, et al.SAR and QSAR in Environmental Research|April 18, 2000
Quantitative structure-activity studies of octopaminergic agonists and antagonists against Locusta migratoria using similarity indexesA Hirashima, K Shinkai, E Kuwano, et al.Journal of Bacteriology|September 1, 1976
Novel mutation that causes a structural change in a lipoprotein in the outer membrane of Escherichia coliH Suzuki, Y Nishimura, H Iketani, et al.Bioscience, Biotechnology, and Biochemistry|July 9, 2016
Synthesis and Octopaminergic-agonist Activity of 3-(Substituted Phenyl)imidazolidine-2-thiones and Related CompoundsA Hirashima, K Shinkai, E Kuwano, et al.Bioorganic & Medicinal Chemistry|February 12, 1998
Quantitative structure-activity studies of octopaminergic 2-(arylimino)thiazolidines and oxazolidines against the nervous system of Periplaneta americana LA Hirashima, J Tomita, C Pan, et al.Bioorganic & Medicinal Chemistry|August 28, 1999
Three-dimensional pharmacophore hypotheses for the locust neuronal octopamine receptor (OAR3). Part 2: agonistsA Hirashima, C Pan, E Kuwano, et al.Pageof 6